Influence of Ligustrazine Hydrochloride Injection Combined Buyang Huanwu Tang to Intervention on Blood Viscosity and Coagulation Factor with Acute Cerebral Infarction Patients
|更新时间:2024-09-23
|
Influence of Ligustrazine Hydrochloride Injection Combined Buyang Huanwu Tang to Intervention on Blood Viscosity and Coagulation Factor with Acute Cerebral Infarction Patients
Chinese Journal of Experimental Traditional Medical FormulaeVol. 21, Issue 24, Pages: 161-164(2015)
TANG Shi-lei, GAO Yuan-lin. Influence of Ligustrazine Hydrochloride Injection Combined Buyang Huanwu Tang to Intervention on Blood Viscosity and Coagulation Factor with Acute Cerebral Infarction Patients[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(24): 161-164.
DOI:
TANG Shi-lei, GAO Yuan-lin. Influence of Ligustrazine Hydrochloride Injection Combined Buyang Huanwu Tang to Intervention on Blood Viscosity and Coagulation Factor with Acute Cerebral Infarction Patients[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(24): 161-164. DOI: 10.13422/j.cnki.syfjx.2015240161.
Influence of Ligustrazine Hydrochloride Injection Combined Buyang Huanwu Tang to Intervention on Blood Viscosity and Coagulation Factor with Acute Cerebral Infarction Patients
Objective: To investigate the influence of ligustrazine hydrochloride injection combined with Buyang Huanwu Tang to blood viscosity and blood coagulation factor on acute cerebral infarction. Method: One hundred and ten patients with acute cerebral infarction were randomly divided into control group(55 cases) and observation group(55 cases) by random number table. Both groups received aspirin enteric-coated tablets
100 mg/time
1 time/day
dipyridamole tablets
50 mg/time
3 time/day. Based on the treatment of control group
patients in observation group added ligustrazine hydrochloride injection combined with Buyang Huanwu Tang. Courses of treatment in two groups were both 14 days. Scores of neurologic impairment were graded by national institutes of health stroke scale(NIHSS). Before and after treatment
levels of blood rheology target
D-dimer(D-D)
maximum platelet aggregation rate(MPAR)
von Willebrand factor(vWF)
prothrombin time(PT)
activated partial thromboplastin time(APTT)
thrombin time(TT)
fibrinogen(FIB) were detected. Result: Total effective rate in observation group was 90.91% higher than that in control group(76.36%)
with significant difference(P<0.05). At the fourteenth day after treatment
NHISS score in the observation group was lower than that in control group(P<0.05). Levels of D-D
MPAR and vWF were lower than those in control group(P<0.05
P<0.01). Levels of whole blood viscosity(high and low shearing)
plasmic viscosity and erythrocyte sedimentation rate were also lower than those in control group(P<0.05
P<0.01). Compared with the data before treatment
levels of PT
APTT and TT in both groups increased(P<0.01)
and they were more obvious in observation group(P<0.05). And FIB decreased in both groups compared with the data before therapy
it was more obvious in observation group(P<0.01). Conclusion: Based on the conventional western medicine treatment
ligustrazine hydrochloride injection combined with Buyang Huanwu Tang on can improve blood fluidity with acute cerebral infarction patients
enhance the neural function recovery of patients and increase the clinical curative effect.
Clinical Research on Taohong Sanchong Decoction for Treatment of Acute Cerebral Infarction
Clinical Research on Taohong Sanchong Decoction for Treatment of Acute Cerebral Infarction
Effect of Tongnaoyin on Cerebral Hemodynamics in Patients with Acute Cerebral Infarction of Phlegm and Blood Stasis Syndrome Based on CTA/CTP
Comparison on Rat Models of Acute Cerebral Infarction Due to Stasis Combined with Toxin Complicated with Cerebral-cardiac Syndrome
Clinical Effect of Erchentang and Bixie Fenqingyin Combined on Patients with Acute Cerebral Infarction with Hyperuricemia with Syndrome of Phlegm and Blood Stasis Blocking Collaterals
Related Author
MA Zhi-heng
SHI Zhi-qin
ZHANG Han-xin
GAO Zhi-sheng
HUANG Mei-qin
Wang Jing
MA Zhi-heng
SHI Zhi-qin
Related Institution
Xinhua Chongming Hospital,Shanghai Jiaotong University
The Affiliated Hospital of Nanjing University of Chinese Medicine/ Jiangsu Province Hospital of Chinese Medicine
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Beijing Key Laboratory of Pharmacology of Chinese Materia Medica,Institute of Basic Medical Sciences,Xiyuan Hospital,China Academy of Chinese Medical Sciences
Shanghai Yangzhi Rehabilitation Hospital(Shanghai Sunshine Rehabilitation Center), Tongji University School of Medicine